2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases.


Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2022
Historique:
entrez: 13 12 2021
pubmed: 14 12 2021
medline: 24 2 2022
Statut: ppublish

Résumé

We have carried out the design, synthesis, and evaluation of a small library of 2-aminobenzoxazole-appended coumarins as novel inhibitors of tumour-related CAs IX and XII. Substituents on C-3 and/or C-4 positions of the coumarin scaffold, and on the benzoxazole moiety, together with the length of the linker connecting both units were modified to obtain useful structure-activity relationships. CA inhibition studies revealed a good selectivity towards tumour-associated CAs IX and XII (

Identifiants

pubmed: 34894971
doi: 10.1080/14756366.2021.1998026
pmc: PMC8667885
doi:

Substances chimiques

Antineoplastic Agents 0
Benzoxazoles 0
Carbonic Anhydrase Inhibitors 0
Coumarins 0
Isoenzymes 0
Carbonic Anhydrases EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-177

Références

J Enzyme Inhib Med Chem. 2012 Feb;27(1):138-47
pubmed: 21815773
Int J Mol Sci. 2020 Jan 04;21(1):
pubmed: 31947992
Curr Med Chem. 2011;18(25):3929-51
pubmed: 21824098
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1702-1714
pubmed: 34325588
J Med Chem. 2010 Jan 14;53(1):335-44
pubmed: 19911821
Br J Cancer. 2012 Feb 28;106(5):916-22
pubmed: 22333602
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1442-1449
pubmed: 32614678
Food Chem Toxicol. 1994 Apr;32(4):357-63
pubmed: 8206431
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1462-1470
pubmed: 32779543
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1555-1561
pubmed: 32746643
Eur J Med Chem. 2018 Feb 25;146:287-298
pubmed: 29407958
Eur J Med Chem. 2019 Nov 1;181:111565
pubmed: 31387062
J Med Chem. 2011 Dec 22;54(24):8271-7
pubmed: 22077347
Int J Mol Sci. 2020 Jun 29;21(13):
pubmed: 32610556
Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3
pubmed: 20674354
J Med Chem. 2020 May 28;63(10):5185-5200
pubmed: 32364386
Bioorg Chem. 2020 Mar;96:103618
pubmed: 32059152
Eur J Med Chem. 2018 Jan 1;143:958-969
pubmed: 29232586
Biochem J. 2016 Jul 15;473(14):2023-32
pubmed: 27407171
Physiol Rev. 2000 Apr;80(2):681-715
pubmed: 10747205
Eur J Med Chem. 2019 Oct 1;179:493-501
pubmed: 31271961
Chem Biol Drug Des. 2021 Oct;98(4):655-673
pubmed: 34233082
Molecules. 2018 Jan 27;23(2):
pubmed: 29382051
Int J Biol Macromol. 2020 Nov 1;162:774-780
pubmed: 32574739
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Eur J Med Chem. 2017 May 26;132:42-62
pubmed: 28340413
Expert Opin Ther Pat. 2018 Oct;28(10):709-712
pubmed: 30217119
Front Chem. 2018 Jul 03;6:247
pubmed: 30018949
Nat Prod Rep. 2015 Sep 23;32(10):1472-507
pubmed: 26151411
Expert Opin Ther Pat. 2013;23(6):717-24
pubmed: 23514045
Bioorg Chem. 2020 Jul;100:103908
pubmed: 32413632
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1199-1209
pubmed: 31237458
J Enzyme Inhib Med Chem. 2021 Dec;36(1):450-461
pubmed: 33557646
Chem Biol Interact. 2016 Jul 25;254:11-23
pubmed: 27174134
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1607-1621
pubmed: 34281458
Mol Cancer Ther. 2018 Dec;17(12):2598-2609
pubmed: 30254183
Front Oncol. 2020 Dec 04;10:592853
pubmed: 33344242
Future Med Chem. 2018 Mar 1;10(5):561-573
pubmed: 29478330
Nat Rev Drug Discov. 2011 Sep 16;10(10):767-77
pubmed: 21921921
Nat Commun. 2020 Sep 11;11(1):4557
pubmed: 32917908
Eur J Med Chem. 2020 Mar 1;189:112013
pubmed: 31972390
J Enzyme Inhib Med Chem. 2016 Dec;31(6):894-9
pubmed: 26607399
J Med Chem. 2020 Mar 12;63(5):2325-2342
pubmed: 31689108
Bioorg Chem. 2019 Jun;87:838-850
pubmed: 31003041
Eur J Med Chem. 2018 Jan 1;143:276-282
pubmed: 29197732
Bioorg Chem. 2020 Oct;103:104163
pubmed: 32890989
ISME J. 2019 Aug;13(8):2094-2106
pubmed: 31024153
J Enzyme Inhib Med Chem. 2021 Dec;36(1):685-692
pubmed: 33602041
J Enzyme Inhib Med Chem. 2013 Dec;28(6):1129-42
pubmed: 23294106
J Am Chem Soc. 2009 Mar 4;131(8):3057-62
pubmed: 19206230
Annu Rev Physiol. 1996;58:523-38
pubmed: 8815807
Int J Mol Sci. 2019 Sep 24;20(19):
pubmed: 31554165
Bioorg Chem. 2020 Jul;100:103907
pubmed: 32413631

Auteurs

Alma Fuentes-Aguilar (A)

Facultad de Ciencias Químicas, Ciudad Universitaria, Benemérita Universidad Autónoma de Puebla, Puebla, México.

Penélope Merino-Montiel (P)

Facultad de Ciencias Químicas, Ciudad Universitaria, Benemérita Universidad Autónoma de Puebla, Puebla, México.

Sara Montiel-Smith (S)

Facultad de Ciencias Químicas, Ciudad Universitaria, Benemérita Universidad Autónoma de Puebla, Puebla, México.

Socorro Meza-Reyes (S)

Facultad de Ciencias Químicas, Ciudad Universitaria, Benemérita Universidad Autónoma de Puebla, Puebla, México.

José Luis Vega-Báez (JL)

Facultad de Ciencias Químicas, Ciudad Universitaria, Benemérita Universidad Autónoma de Puebla, Puebla, México.

Adrián Puerta (A)

BioLab, Instituto Universitario de Bio-Orgánica "Antonio González" (IUBO-AG), Universidad de La Laguna, La Laguna, Spain.

Miguel X Fernandes (MX)

BioLab, Instituto Universitario de Bio-Orgánica "Antonio González" (IUBO-AG), Universidad de La Laguna, La Laguna, Spain.

José M Padrón (JM)

BioLab, Instituto Universitario de Bio-Orgánica "Antonio González" (IUBO-AG), Universidad de La Laguna, La Laguna, Spain.

Andrea Petreni (A)

NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Florence, Italy.

Alessio Nocentini (A)

NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Florence, Italy.

Claudiu T Supuran (CT)

NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Florence, Italy.

Óscar López (Ó)

Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Seville, Spain.

José G Fernández-Bolaños (JG)

Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Seville, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH